Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

6.3

Presumed severe HIV disease in infants (PSHD)

Clinical HIV Guidelines, 5th Edition, 2022. Chapter 6, Diagnosing HIV infection and exposure.

Clinical description

  • Infants infected with HIV develop life-threatening HIV-related disease much more quickly than

older children and adults.

  • Conduct point of care DNA-PCR testing on site for timely clinical decision making, if available.
  • However, it may take too long to confirm HIV infection in a sick infant using DNA-PCR.
  • Under the age of 12 months, a positive HIV rapid antibody test does not confirm HIV infection

because maternal antibodies pass through the placenta and remain in the baby’s blood for several months.

  • However, a positive rapid antibody test in an infant with the following clinical signs makes severe

HIV disease (AIDS) very likely:

Table 4: Definition of presumed severe HIV disease (PSHD)

Table 4 — Definition of presumed severe HIV disease (PSHD)
Table 4 — Definition of presumed severe HIV disease (PSHD). Open the image to zoom.

Infant with positive rapid antibody test PLUS:

Combination of 2: OR At least 1:

  • Oral thrush • Severe unexplained wasting / malnutrition not

responding to treatment

  • Severe pneumonia
  • Pneumocystis pneumonia
  • Severe sepsis
  • Candidiasis of oesophagus, trachea, bronchi or lungs
  • Cryptococcal meningitis
  • Cerebral Toxoplasmosis (from age 1 month)
  • Start ART as quickly as possible for infants with PSHD – do not wait for a DNA-PCR result.
  • Collect a DBS sample for DNA-PCR confirmatory testing on the day of starting ART (see section 16.3

on page 78).

Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.